Approval for the Medtronic AVE GFX(R) 2 Over-The-Wire Coronary Stent System.  The device is indicated for improving coronary luminal diameter in patients with symptomatic ischemic heart disease due to discrete de novo lesions (length < 30 mm) in native coronary arteries with reference vessel diameters ranging from 3.0 mm to 4.0 mm.  Long term outcome (beyond six months) for this permanent implant is unknown at present.